COVID-19 spike-host cell receptor GRP78 binding site prediction
- PMID: 32169481
- PMCID: PMC7102553
- DOI: 10.1016/j.jinf.2020.02.026
COVID-19 spike-host cell receptor GRP78 binding site prediction
Abstract
Objectives: Understanding the novel coronavirus (COVID-19) mode of host cell recognition may help to fight the disease and save lives. The spike protein of coronaviruses is the main driving force for host cell recognition.
Methods: In this study, the COVID-19 spike binding site to the cell-surface receptor (Glucose Regulated Protein 78 (GRP78)) is predicted using combined molecular modeling docking and structural bioinformatics. The COVID-19 spike protein is modeled using its counterpart, the SARS spike.
Results: Sequence and structural alignments show that four regions, in addition to its cyclic nature have sequence and physicochemical similarities to the cyclic Pep42. Protein-protein docking was performed to test the four regions of the spike that fit tightly in the GRP78 Substrate Binding Domain β (SBDβ). The docking pose revealed the involvement of the SBDβ of GRP78 and the receptor-binding domain of the coronavirus spike protein in recognition of the host cell receptor.
Conclusions: We reveal that the binding is more favorable between regions III (C391-C525) and IV (C480-C488) of the spike protein model and GRP78. Region IV is the main driving force for GRP78 binding with the predicted binding affinity of -9.8 kcal/mol. These nine residues can be used to develop therapeutics specific against COVID-19.
Keywords: BiP; COVID-19 spike; GRP78; Pep42; Protein-protein docking; Structural bioinformatics.
Copyright © 2020. Published by Elsevier Ltd.
Conflict of interest statement
Declaration of Competing Interests All of the authors declare that there is no competing interest in this work.
Figures
Comment in
-
A possible role for GRP78 in cross vaccination against COVID-19.J Infect. 2021 Feb;82(2):282-327. doi: 10.1016/j.jinf.2020.09.004. Epub 2020 Sep 10. J Infect. 2021. PMID: 32920062 Free PMC article. No abstract available.
References
-
- Organization WH. World Health Organization; 2020. Surveillance case definitions for human infection with novel coronavirus ( nCoV): interim guidance v1, January 2020.
-
- Organization WH . World Health Organization; 2020. Laboratory testing of human suspected cases of novel coronavirus ( nCoV) infection: interim guidance, 10 January 2020.
-
- Organization WH . World Health Organization; 2020. Infection prevention and control during health care when novel coronavirus ( nCoV) infection is suspected: interim guidance, January 2020.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
